Tag: Boehringer Ingelheim

March 26, 2019
7 Potential Blockbuster Drugs Investors Should Watch for in 2019
A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
November 15, 2018
Boehringer Ingelheim Partners with Epizyme
Boehringer Ingelheim and Epizyme announced a partnership on Thursday to develop oncology treatments.The partnership entails developing, researching and commercializing small...
June 25, 2018
Boehringer Ingelheim and Eli Lilly Share Positive Phase 3 Results
Empaglifozin was used in those trials in combination with traditional insulin therapy to evaluate if it could provide blood sugar... June 25, 2018